Amy E. Blum

Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary results from KEYNOTE-012 expansion cohort.

Tanguy Y. Seiwert, Robert I. Haddad, Shilpa Gupta et al. · Journal of Clinical Oncology · 2015 · 103 citations

Antitumor Activity, Immunology, Immunoediting +21

Assessment of outcomes of calciphylaxis

Colleen K. Gabel, Emily Nguyen, Teja Chakrala et al. · Journal of the American Academy of Dermatology · 2020 · 29 citations

Medicine, Patient Safety, Poisoning

Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity

Leah L. Thompson, E.B. Li, Nira A. Krasnow et al. · British Journal of Dermatology · 2021 · 22 citations

Antitumor activity and safety of pembrolizumab in patients (pts) with advanced squamous cell carcinoma of the head and neck (SCCHN): Preliminary results from KEYNOTE-012 expansion cohort.

Tanguy Y. Seiwert, Robert I. Haddad, Shilpa Gupta et al. · Journal of Clinical Oncology · 2015 · 21 citations

Antitumor Activity, Cancer Management, Pathology +18

What people prefer and what they think they prefer in short- and long-term partners. The effects of the phase of the menstrual cycle, hormonal contraception, pregnancy, and the marital and the parenthood status on partner preferences

Jaroslav Flegr, Amy E. Blum, Ondřej Nekola et al. · Evolution and Human Behavior · 2018 · 19 citations

Contraception, Behavioral Sciences, Intimate Relationship +12